Factors Associated with Reported COVID-like Symptoms and Seroprevalence Data Matched with COVID-like Symptoms in Slums and Non-Slums of Two Major Cities in Bangladesh.
Bangladesh
non-slum
reported COVID-19
seroprevalence
slum
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
16 May 2023
16 May 2023
Historique:
received:
30
03
2023
revised:
10
05
2023
accepted:
10
05
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
To examine the levels and socio-demographic differentials of: (a) reported COVID-like symptoms; and (b) seroprevalence data matched with COVID-like symptoms. Survey data of reported COVID-like symptoms and seroprevalence were assessed by Roche Elecsys The odds of COVID-like symptoms were significantly higher for Chattogram city, for non-slum, people having longer years of schooling, working class, income-affected households, while for households with higher income had lower odd. The odds of matched seroprevalence and COVID-like symptoms were higher for non-slum, people having longer years of schooling, and for working class. Out of the seropositive cases, 37.77% were symptomatic-seropositive, and 62.23% were asymptomatic, while out of seronegative cases, 68.96% had no COVID-like symptoms. Collecting community-based seroprevalence data is important to assess the extent of exposure and to initiate mitigation and awareness programs to reduce COVID-19 burden.
Identifiants
pubmed: 37239730
pii: healthcare11101444
doi: 10.3390/healthcare11101444
pmc: PMC10218417
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : This research was funded by THE FOREIGN, COMMONWEALTH & DEVELOPMENT OFFICE (FCDO) through THE UNITED NATIONS POPULATION FUND (UNFPA), and GLOBAL AFFAIRS CANADA
ID : grant number-01967,01686
Références
J Health Popul Nutr. 2011 Oct;29(5):523-31
pubmed: 22106759
IJID Reg. 2021 Dec;1:92-99
pubmed: 35721768
BMC Infect Dis. 2021 Apr 7;21(1):325
pubmed: 33827460
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Cochrane Database Syst Rev. 2021 Feb 23;2:CD013665
pubmed: 33620086
Nat Commun. 2021 Jun 15;12(1):3643
pubmed: 34131124
Nature. 2020 Nov;587(7835):534-535
pubmed: 33214725
BMJ. 2020 Oct 23;371:m3862
pubmed: 33097561
PLoS One. 2022 May 23;17(5):e0268093
pubmed: 35604947
Int J Environ Res Public Health. 2021 Aug 18;18(16):
pubmed: 34444450
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
J Trop Pediatr. 2001 Apr;47(2):98-105
pubmed: 11336143
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Med Virol. 2020 Oct;92(10):1761-1763
pubmed: 32275074
Expert Rev Respir Med. 2022 Mar;16(3):263-272
pubmed: 35245149
Infection. 2020 Apr;48(2):155-163
pubmed: 32072569
Qual Health Res. 2022 Jun;32(7):1114-1125
pubmed: 35543221
Heliyon. 2021 Jun;7(6):e07385
pubmed: 34189333
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Mol Histol. 2020 Dec;51(6):613-628
pubmed: 33011887